Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2008-3-3
pubmed:abstractText
The mouse is refractory to lithogenic agents active in rats and humans, and so has been traditionally considered a poor experimental model for nephrolithiasis. However, recent studies have identified slc26a6 as an oxalate nephrolithiasis gene in the mouse. Here we extend our earlier demonstration of different anion selectivities of the orthologous mouse and human SLC26A6 polypeptides to investigate the correlation between species-specific differences in SLC26A6 oxalate/anion exchange properties as expressed in Xenopus oocytes and in reported nephrolithiasis susceptibility. We find that human SLC26A6 mediates minimal rates of Cl(-) exchange for Cl(-), sulphate or formate, but rates of oxalate/Cl(-) exchange roughly equivalent to those of mouse slc2a6. Both transporters exhibit highly cooperative dependence of oxalate efflux rate on extracellular [Cl(-)], but whereas the K(1/2) for extracellular [Cl(-)] is only 8 mM for mouse slc26a6, that for human SLC26A6 is 62 mM. This latter value approximates the reported mean luminal [Cl(-)] of postprandial human jejunal chyme, and reflects contributions from both transmembrane and C-terminal cytoplasmic domains of human SLC26A6. Human SLC26A6 variant V185M exhibits altered [Cl(-)] dependence and reduced rates of oxalate/Cl(-) exchange. Whereas mouse slc26a6 mediates bidirectional electrogenic oxalate/Cl(-) exchange, human SLC26A6-mediated oxalate transport appears to be electroneutral. We hypothesize that the low extracellular Cl(-) affinity and apparent electroneutrality of oxalate efflux characterizing human SLC26A6 may partially explain the high human susceptibility to nephrolithiasis relative to that of mouse. SLC26A6 sequence variant(s) are candidate risk modifiers for nephrolithiasis.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18174209-10541256, http://linkedlifedata.com/resource/pubmed/commentcorrection/18174209-10916098, http://linkedlifedata.com/resource/pubmed/commentcorrection/18174209-11135080, http://linkedlifedata.com/resource/pubmed/commentcorrection/18174209-11733634, http://linkedlifedata.com/resource/pubmed/commentcorrection/18174209-12119287, http://linkedlifedata.com/resource/pubmed/commentcorrection/18174209-12217875, http://linkedlifedata.com/resource/pubmed/commentcorrection/18174209-12407081, http://linkedlifedata.com/resource/pubmed/commentcorrection/18174209-12506146, http://linkedlifedata.com/resource/pubmed/commentcorrection/18174209-12651923, http://linkedlifedata.com/resource/pubmed/commentcorrection/18174209-1474373, http://linkedlifedata.com/resource/pubmed/commentcorrection/18174209-15252407, http://linkedlifedata.com/resource/pubmed/commentcorrection/18174209-15480750, http://linkedlifedata.com/resource/pubmed/commentcorrection/18174209-15496160, http://linkedlifedata.com/resource/pubmed/commentcorrection/18174209-15548529, http://linkedlifedata.com/resource/pubmed/commentcorrection/18174209-15601675, http://linkedlifedata.com/resource/pubmed/commentcorrection/18174209-16200192, http://linkedlifedata.com/resource/pubmed/commentcorrection/18174209-16373425, http://linkedlifedata.com/resource/pubmed/commentcorrection/18174209-16508976, http://linkedlifedata.com/resource/pubmed/commentcorrection/18174209-16518326, http://linkedlifedata.com/resource/pubmed/commentcorrection/18174209-16532010, http://linkedlifedata.com/resource/pubmed/commentcorrection/18174209-16606687, http://linkedlifedata.com/resource/pubmed/commentcorrection/18174209-16682411, http://linkedlifedata.com/resource/pubmed/commentcorrection/18174209-16850020, http://linkedlifedata.com/resource/pubmed/commentcorrection/18174209-17442754, http://linkedlifedata.com/resource/pubmed/commentcorrection/18174209-17520699, http://linkedlifedata.com/resource/pubmed/commentcorrection/18174209-17538185, http://linkedlifedata.com/resource/pubmed/commentcorrection/18174209-17998209, http://linkedlifedata.com/resource/pubmed/commentcorrection/18174209-18310129, http://linkedlifedata.com/resource/pubmed/commentcorrection/18174209-2342249, http://linkedlifedata.com/resource/pubmed/commentcorrection/18174209-3003149, http://linkedlifedata.com/resource/pubmed/commentcorrection/18174209-5415681, http://linkedlifedata.com/resource/pubmed/commentcorrection/18174209-5415682, http://linkedlifedata.com/resource/pubmed/commentcorrection/18174209-7131093, http://linkedlifedata.com/resource/pubmed/commentcorrection/18174209-7922303, http://linkedlifedata.com/resource/pubmed/commentcorrection/18174209-8663096, http://linkedlifedata.com/resource/pubmed/commentcorrection/18174209-8741736
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1469-7793
pubmed:author
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
586
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1291-306
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Species differences in Cl- affinity and in electrogenicity of SLC26A6-mediated oxalate/Cl- exchange correlate with the distinct human and mouse susceptibilities to nephrolithiasis.
pubmed:affiliation
Molecular and Vascular Medicine Unit and Renal Division, Beth Israel Deaconess Medical Center and Department of Medicine, Harvard Medical School, Boston, MA 02215, USA.
pubmed:publicationType
Journal Article, Comparative Study
More...